dark green.png

Disease doesn’t wait. And it doesn’t care where you live.

We believe that access to medicine should be global by design, whether pre-approval, commercially available or long-term unlicensed.

Get in touch
rarediseaseday.jpg

Reaching more patients, touching more lives.

Our unique combination of services enables quicker access to innovative medicines for patients in every corner of the globe.

We accelerate access across the lifecycle: 
Pre-approval: Early access | Compassionate use | Named patient | Charged for | Post-trial
Post-approval (by country, region or global): Licensed distribution | Non-launch distribution | Withdrawal market distribution 

We are able to support clients on a global basis, providing not only an unrivalled regulatory affairs team, but also the critical patient safety services that are essential to the provision of safe, compliant and timely access.  Our client partnerships take various forms – from service provision to acting as your global or regional affiliate – but are always founded on flexibility, ensuring you retain control of your product and doing our very best to make sure no patient is left behind.